Consortium for Immunoinflammatory Drug Discovery launched

Daiichi Sankyo, Tanabe Mitsubishi Pharmaceutical, Ono Pharmaceutical, Keio University, Kochi University, and the National Institute of Health and Nutrition have launched joint research on the pathophysiology of immunoinflammatory diseases and related research on drug discovery.

Source: Nikkei Biotech news release, May 31, 2018

Request a quote for deeper information from

© 2018 Window to Japan - Bio 4 Business - Imprint